Summary The cellular distribution of 4-borono-2-["8F]fluoro-L-phenylalanine (['8F]FBPA, an analog of pboronophenylaline), a potential agent for boron neutron capture therapy (BNCT), and [6-3H]thymidine ([3H]Thd, a DNA precursor) in murine two B16 melanoma sublines and FM3A mammary carcinoma was studied in vivo using double-tracer microautoradiography. Tumour volume, tumour age, cell density in the tissues and the proportion of S phase cells in the cell cycle were the same in the three tumour models. Volume doubling time, which represents tumour growth rate, was fastest in B16F10, followed by B16F1 (P <0.05), the slowest being in FM3A (P<0.001). p-Boronophenylalanine (BPA) has been studied as a potential agent for boron neutron capture therapy (BNCT) for melanomas (Mishima et al., 1989a,b). The success of this treatment is dependent on the highly selective localisation and concentration of boron-10 in tumours vs normal tissues. Biodistribution studies and radiation dosimetry based on pharmacokinetics have indicated that BPA acts as a biochemically targeted boron carrier for melanomas in vivo (Barth et al., 1990; Coderre et al., 1988) . Double-labelled neutron capture radiograms of '°B-L-BPA and [3H]Thd autoradiograms from the same whole-body section showed that high concentration of boron in the tumour corresponded closely with areas of rapid cell division (Coderre et al., 1987). However, the relationship of BPA accumulation to DNA synthesis and pigmentation is still unclear (Tsuji et al., 1983; Ichihashi et al., 1982; Ishiwata et al., 1992a) .
p-Boronophenylalanine (BPA) has been studied as a potential agent for boron neutron capture therapy (BNCT) for melanomas (Mishima et al., 1989a,b) . The success of this treatment is dependent on the highly selective localisation and concentration of boron-10 in tumours vs normal tissues. Biodistribution studies and radiation dosimetry based on pharmacokinetics have indicated that BPA acts as a biochemically targeted boron carrier for melanomas in vivo (Barth et al., 1990; Coderre et al., 1988) . Double-labelled neutron capture radiograms of '°B-L-BPA and [3H]Thd autoradiograms from the same whole-body section showed that high concentration of boron in the tumour corresponded closely with areas of rapid cell division (Coderre et al., 1987) . However, the relationship of BPA accumulation to DNA synthesis and pigmentation is still unclear (Tsuji et al., 1983; Ichihashi et al., 1982; Ishiwata et al., 1992a) .
In recent studies carried out to accurately determine the in vivo concentration of the compound, '8F labelled boronophenylalanine (4-borono-2-['8F]fluoro-L-phenylalanine; ['8F ]-FBPA) has been synthesised as a positron emitting tracer which can be quantified non-invasively in vivo by positron emission tomography (PET) (Ishiwata et al., 1991a,b; 1992a,b) . Chemically determined '0B-BPA concentration in the Greene's melanomas was comparable to the value estimated with ['8F ]FBPA . Thus ["8F]-FBPA showed potential value for non-invasive BNCT dosimetry with '0B-BPA.
High selectivity of ['8F ]FBPA for B16 melanoma (wild type) (Ishiwata et al., 1991b) and FM3A tumour in mice was reported in both whole-body autoradiography and tissue distribution study. The tumours showed 3.2 to 8.1 times higher uptake of ['8F]FBPA than the normal tissues except pancreas and kidney, of which tracer distribution pattern is typical for amino acid analogs. The investigation of the biochemical and physiological mechanisms by which the boron compound concentrates in tumours Correspondence: R. Kubota is important for assessing the cell biological efficacy of the compound in BNCT (Barth et al., 1990) .
In our previous study (Kubota et (Ishiwata et al., 1991a . The double-tracer experiment and micro-ARG were performed as described previously in detail (Kubota et al., 1992a) (Yamada et al., 1990) .
Under a safety light, frozen 5-.m sections were directly mounted on slides coated with NTB2 emulsion. After 4 h of exposure under dry ice cold, the sections were fixed with 5% acetic acid; the autoradiograms were developed in Konidol-X (Konica, Japan), fixed in Kodak general purpose fixer (Kodak, Japan), washed, and dried. Three days after the first ARG for the complete decay of '8F (t1/2= 109.8 min), the second ARG was processed with ET2F stripping film. Under a safety light, the slides with sections and the first autoradiogram were covered with ET2F stripping film; the film-coated slides were then exposed for 3 weeks. After exposure, the films were developed, fixed, washed, and dried as described above. The specimens were stained with hematoxylin and eosin. Grain counts were obtained by focusing a transmitted light brightfield microscope alternately on the upper and lower emulsion layers, using a micrometer. Non-radioactive tumour sections were included in each group on a separate slide as a chemographic control.
The relationship between grain numbers and '8F radioactivity was determined using liver sections of mice injected with '8F-tracer at different doses, as uniform step-wise standards of radioactive sample (Kubota et al., 1992a,b) . A linear relationship between grain numbers per 100 ILm2 (Y) and the corresponding '8F radioactivity (fCi/100 pm2, X) (Y = 0.42 X + 0.35, n = 40, r = 0.9996, P<0.001) has been observed. This finding supported the validity of the grain counting method used in this study for the quantification of '8F micro-ARG. The quantitative characteristics of [3H]Thd micro-ARG have been studied for 40 years and have been established as a marker of de novo DNA synthesis (Cory & Whitford, 1972; Tsuya et al., 1979) . Self-absorption, which reduces the fraction of particles from 3H in the specimen that can reach the emulsion, was considered to be comparable in the three types of tumour tissues, in which there were no significant differences in section thickness and cell density, and which were processed under the same conditions throughout. The background level was subtracted from the relevant data. Melanoma cells were microscopically classified according to the
degree of pigmentation, as graded by Bennett (1983) : unpigmented and very lightly pigmented cells were classified as non-melanocytes, and lightly, moderately, and well-pigmented cells were classified as melanocytes. Tumour growth curves were determined from the products of three principal diameters of the in vivo tumours (Kubota et al., 1983) Figure 2 shows the growth curves of the three tumour models. The tracer study was performed 11 ± 0.5 days after transplantation when the tumours grew to the same size in order to unify the experimental condition of animals. Figure 1 shows the histological characteristics of both subcloned melanoma cell lines as well as the differences of melanin content in melanocytes. were randomly selected and averaged. (Skog et al., 1990; Hessels et al., 1991) . A slow progression through the cell cycle was shown to be accompanied by a reduced DNA synthesis rate (Harada & Morris, 1981; Santavenere et al., 1991) . In this present study, while all three tumour models showed the same S phase proportion, the DNA synthesis rate was significantly greater in B16F10. Increased DNA synthesis has been shown to be accompanied by increased protein synthesis (Bagby et al., 1992) ; the increased protein synthesis rate can be considered to stimulate amino acid transport/ demand. ['8F]FBPA accumulation, as well as BPA accumulation, by the tumour is considered to be dependent on the amino acid transport system (Tsuji et al., 1983; Coderre et al., 1988) . The transport/demand into the cells is related to the activity of DNA synthesis; however it appears that the accumulated ['8F]FBPA does not incorporate into protein synthesis, as shown by the finding of Ishiwata et al. (1992a) that [ ['8F ]FBPA participation in melanin production.
In conclusion, we consider that two independent mechanisms account for [18F] FBPA accumulation in the tumour cells. The primary one is amino acid transport/demand which responds to the activity of DNA synthesis, the rate of DNA synthesis being related to the in vivo tumour growth rate. The
["8F]FBPA accumulated by this mechanism does not incorporate into protein synthesis. The second mechanism is melanin incorporation, which is increased with melanin content. The metabolism is unclear, but the participation in melanin production is considered. These observations regarding tracer uptake mechanisms suggest that the therapeutic efficacy of BNCT using BPA may be higher in melanomas that have high DNA synthesis activity, therefore high growth rate, and high melanin content. We hope this study will aid in the understanding of the pharmacokinetics of '°B-BPA in melanoma. The relative concentration of this compound can be assessed non-invasively in vivo by PET, using a 18F-labelled tracer; ['8F]FBPA. The development of positron-labelled boron compounds and the study of their kinetics may be a new approach for making progress with BNCT.
